Roche Corleen M. has filed 8 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 132200 shares of IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) on March 09, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Roche Corleen M. | Chief Financial Officer | A | Restricted Stock Units | 132200 | $0.00 | 132,200.0000 | 357,345 | 9999.99% | 37.00% |
| Aug. 6, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Roche Corleen M. | Chief Financial Officer | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 334,511 | 9999.99% | 89.68% |
| Aug. 6, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Roche Corleen M. | Chief Financial Officer | A | Restricted Stock Units | 150000 | $0.00 | 150,000.0000 | 334,511 | 9999.99% | 44.84% |
| April 15, 2025 | CG Oncology, Inc. | $CGON | Roche Corleen M. | CFO | A | Employee Stock Option (Right to Buy) | 143907 | $0.00 | 143,907.0000 | 76,216,855 | 9999.99% | 0.19% |
| Oct. 4, 2024 | CG Oncology, Inc. | $CGON | Roche Corleen M. | CFO | A | Stock Option (Right to Buy) | 93600 | $0.00 | 93,600.0000 | 0 | 9999.99% | 0.00% |
| Jan. 29, 2024 | CG Oncology, Inc. | $CGON | Roche Corleen M. | CFO & Secretary | P | Common Stock | 2000 | $19.00 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2024 | CG Oncology, Inc. | $CGON | Roche Corleen M. | CFO & Secretary | A | Stock Option | 492920 | $0.00 | 492,920.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Immunome Inc. | $IMNM | Roche Corleen M. | Chief Financial Officer | A | Stock Option (Right to Buy) | 58000 | $0.00 | 58,000.0000 | 0 | 9999.99% | 0.00% |